With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Among these features are: AI-Assisted Generation of Drug Formulation Descriptions: In the pharmaceutical industry ... clearly defines the therapeutic use of a drug without overstepping regulatory ...

Though the United States is the global leader in designing chips, the vast majority of chip production happens overseas.